Cargando…
Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data
Studies have shown higher survival rates for patients with Hodgkin lymphoma (HL) treated within clinical trials compared to patients treated outside clinical trials. However, endpoints are often limited to overall survival (OS). In this retrospective cohort study, we investigated the effect of trial...
Autores principales: | Juul, Sidsel Jacobsen, Kicinski, Michal, Schaapveld, Michael, Rossetti, Sára, Aleman, Berthe M. P., Liu, Lifang, van Leeuwen, Flora E., Meijnders, Paul, Krol, Augustinus D. G., Janus, Cécile P. M., Hutchings, Martin, Maraldo, Maja V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098896/ https://www.ncbi.nlm.nih.gov/pubmed/36369842 http://dx.doi.org/10.1111/ejh.13899 |
Ejemplares similares
-
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
por: Cutter, David J., et al.
Publicado: (2015) -
Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics
por: de Vries, Simone, et al.
Publicado: (2018) -
P074: Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients – A Nationwide Danish Cohort Study
por: Rossetti, Sára, et al.
Publicado: (2022) -
P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma
por: Geurts, Yvonne M.G., et al.
Publicado: (2022) -
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors
por: van Eggermond, Anna M, et al.
Publicado: (2017)